Introduction
Drug-induced liver injury (DILI) is a major cause of attrition during both early and late stages of the drug development and marketing process (Meng, 2010) . DILI is usually classified as dose-dependent which is typically reproducible, or unpredictable (idiosyncratic) occurring only in certain susceptible patients and being not overtly dose-dependent (Greer et al., 2010) .
The mechanisms underlying idiosyncratic DILI (iDILI) remain largely unknown. Several factors are thought to be implicated; they include genetic polymorphisms of drug metabolismrelated or HLA genes, liver pathologies of various origins including viral infection, and/or environmental inflammatory stress. Among these factors, inflammation caused by agents such as bacterial lipopolysaccharide (LPS) and pro-inflammatory cytokines, has been shown to exacerbate toxicity of many hepatotoxic chemicals (Roth et al., 1997; Yee et al., 2000) ( Barton et al., 2000) and to induce hepatotoxicity of various drugs associated with idiosyncratic reactions, such as trovafloxacin (Waring et al., 2006; Shaw et al., 2007) and chlorpromazine (CPZ) (Buchweitz et al., 2002) .
The antipsychotic agent CPZ is known to cause hepatotoxicity which includes cholestasis (Hollister, 1957; Regal et al., 1987) , hepatocellular necrosis and phospholipidosis, in some patients (Velayudham and Farrell, 2003) . Various CPZ-induced liver disturbances have also been described in in vivo and in vitro animal models but they were mainly limited to hepatic lesions related to cell death, that were usually amplified by pre-treatment with inflammatory agents (Buchweitz et al., 2002; Gandhi et al., 2010; MacAllister et al., 2013) . No evidence of changes in serum bile acid concentrations and alterations of bile canaliculi were observed in rats treated with LPS and CPZ (Buchweitz et al., 2002) . Obviously, whether cholestatic effects of CPZ are aggravated by concomitant exposure to pro-inflammatory cytokines remains unclear.
LPS and pro-inflammatory cytokines have been reported to alter various liver functions, including drug metabolism and transport. In particular, they down-regulate activity of major cytochromes P450 (CYP) involved in xenobiotic metabolism and also markedly impair phase 2 conjugating enzymes as well as basolateral and canalicular transporters of bile acids and organic anions (Abdel-Razzak et al., 1993; Aitken et al., 2006) . Recently, our group reported that CPZ generated an early oxidative stress, altered mitochondrial membrane potential and disorganized pericanalicular cytoskeletal F-actin distribution in human HepaRG cells. These effects were associated with inhibition of taurocholic acid (TA) efflux (Antherieu et al., DMD #58123 Na + -dependent taurocholic cotransporting polypeptide (NTCP) activity.
Activity of the NTCP transporter was estimated through determination of sodium-dependent intracellular accumulation of radiolabeled TA substrate as previously described (Antherieu et al., 2013) . Briefly, treated cells were incubated with radiolabeled TA for 30 minutes. Cells were then washed twice with PBS and lysed with 0.1 N NaOH. Accumulation of radiolabeled substrates was determined through scintillation counting. Taurocholate accumulation values in the presence of sodium minus accumulation values in the absence of sodium represented NTCP activity.
TA efflux activity.

Cells were first incubated with [
3 H]-TA, a substrate of bile salt pump export (BSEP), for 30 minutes, then washed with PBS and exposed to CPZ, cytokines or both for 2 or 4 hours in a standard buffer containing Ca 2+ and Mg 2+ ions. At the end of the incubation time, cells were washed with PBS and incubated for 5 minutes with a Ca 2+ and Mg 2+ -free buffer in order to disrupt the canalicular tight junctions. Then, they were scraped in 0.1 N NaOH; the remaining radiolabeled substrate was measured through scintillation counting to determine TA efflux (Marion et al., 2012) .
CDF excretion.
After 2 or 4 hours of exposure to CPZ and cytokines individually or simultaneously, cells were incubated with 3μM CDFDA, which is hydrolyzed by intracellular esterases to CDF, a substrate of multidrug resistance-associated protein 2 (MRP2) (Zamek-Gliszczynski et al., 2003) for 20 minutes at 37°C and then washed with PBS. Imaging was done using inverted microscope Zeiss Axiovert 200M and AxioCam MRm.
Quantification of CPZ and its metabolites.
After 1 and 5 days of treatment, incubation media were collected and stored at -20°C until analysis. Cells were washed twice with PBS and then lysed with 0.01N NaOH. An aliquot was used to determine protein concentration and the remaining volume was stored at -20°C until analysis. Concentrations of CPZ and four of its metabolites (Nor-1 CPZ, SO CPZ, 3-OH CPZ and 7-OH CPZ) were determined in both cell lysates and incubation media using an HPLC-MS-MS system. HPLC separation was performed on a C18 column (Hypersil Gold, C18; Particle Size: 1.9µm; 50 x 2.1mm, I.D., ThermoFisher Scientific). Mobile phase A This article has not been copyedited and formatted. The final version may differ from this version. 
Statistical analysis.
One-way ANOVA with Bonferroni's multiple comparison test (GraphPad Prism 5.00) was performed to compare data between CPZ-, cytokine-, cytokine and CPZ-treated cells and control cultures. Each value corresponded to the mean ± standard deviation (SD) of at least three independent experiments. Data were considered significantly different when p < 0.05.
Results
Dose-and time-dependent effects of CPZ and cytokines on HepaRG cell viability.
First, the MTT assay was carried out to estimate cytotoxicity of CPZ, IL-6 and IL-1β in HepaRG cells after one and 5 daily additions. At 5 and 20µM, CPZ elicited no toxicity regardless of treatment duration while at 50µM it caused 90% cell death after 3 additions (data not shown). IL-6 did not alter cell viability at concentrations ranging from 0.01 (1unit/ml) to 1ng/ml regardless of the duration of treatment while at 10ng/ml, it induced a 20% loss in cell viability after 5 daily treatments. IL-1β also caused 20-30% decrease in cell viability at concentrations ranging from 0.1 (20 units/ml) to 1ng/ml after 5 days of treatment (data not shown). Based on these results, nontoxic concentrations of 20µM CPZ, 1ng/ml IL-6 and 0.01ng/ml IL-1β were selected for 1 and 5 day co-treatment while 50µM CPZ was used for short-term co-treatment.
In order to verify whether their viability was affected by co-treatments with cytokines, HepaRG cells were first incubated with IL-6 or IL-1β for 24h prior to simultaneous CPZ DMD #58123 addition for 1 or 5 days. Compared to untreated cells, a significant although modest decrease of cell viability was observed after 5 additions of CPZ with either cytokine (12% and 20% with IL-6 + CPZ and IL-1β + CPZ respectively) ( Fig. 1) .
Effects of cytokines and CPZ on inflammation markers.
Generation of an in vitro inflammatory response with the selected cytokine concentrations was validated by measurement of CRP and IL-8 mRNA and secreted protein levels after 1 and 5 additions of either IL-1β or IL-6. Both cytokines caused a statistically significant increase of CRP mRNA (8-to 95-fold) and protein (12-to 48-fold) levels at both time points compared to corresponding untreated cells ( Fig. 2A, C) , thereby demonstrating an inflammatory response of HepaRG cells. At 20µM CPZ did not cause any significant change in CRP expression, excluding any inflammatory effect of this neuroleptic drug at least up to this concentration.
However, combination of CPZ and IL-6 or IL-1β enhanced increase of CRP mRNAs (53-fold with IL-6 versus 80-fold with IL-6 + CPZ and 8-fold with IL-1β versus 12-fold with IL-1β + CPZ after 5 daily additions) ( Fig. 2A) . Although cytokine-mediated induction of CRP protein was also enhanced by CPZ after 5 simultaneous additions (41-fold by IL-6 versus 48-fold by IL-6 + CPZ and 12-fold by IL-1β versus 14-fold by IL-1β + CPZ), these variations were not statistically significant (Fig. 2C ).
Regardless of treatment duration, IL-8 mRNA and protein levels were not affected by IL-6 and 20µM CPZ individually nor by their combination. By contrast, IL-8 mRNAs were increased by IL-1β alone or associated with CPZ after 1 addition; this induction was lower after 5 additions (Fig. 2B) . Similarly, IL-8 protein was also augmented (5-and 4-fold after 1 and 5 additions respectively) (Fig. 2D ). Secreted IL-1β and IL-6 proteins were undetectable in either untreated or 20µM CPZ-treated HepaRG cells even after 5 additions (data not shown).
Additional experiments were performed with 50µM CPZ, a concentration previously shown to induce early characteristic cholestatic features. At 50µM, CPZ increased IL-8 at both mRNA (3.15-fold) and protein (6.6-fold) levels after 24 hours; induction of IL-8 protein was observed as early as 2 hours. Moreover, IL-1β and IL-6 transcripts were induced by 50µM
CPZ (6.6-and 2.3-fold after 24h) and secreted IL-6 protein became detectable after 4h exposure to 50µM CPZ (Supplemental Figure 1) .
Inhibition of CPZ metabolism by pro-inflammatory cytokines.
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At the selected concentrations and regardless of the duration of treatment, both IL-6 and IL-1β strongly repressed mRNA expression of CYP1A2 (a drop by 67% and 58% respectively) and CYP3A4 (a drop by 90% and 75% respectively), two major CYPs involved in CPZ oxidative metabolism, in HepaRG cells. While CYP1A2 and CYP3A4 transcripts were induced 4-to 6-fold in 20µM CPZ-treated HepaRG cells compared to untreated cells, their induction was abolished in the presence of cytokines (Fig. 3A) . Of note, cytokine-induced inhibition of both cytochromes was attenuated or even completely abolished with IL-1β after 5 additions in CPZ co-treated cells.
Moreover, four CPZ metabolites, Nor-1 CPZ, SO CPZ, 7-OH CPZ and 3-OH CPZ, were quantified by HPLC-MS-MS in culture media and cell lysates after 1 and 5 drug additions.
Detectable amounts of Nor-1 CPZ, SO-CPZ and to a lesser extent 7-OH CPZ, were found in both cell lysates ( Fig. 3B ) and incubation media ( 
Time-dependent effects of CPZ and cytokines on phospholipidosis induction.
Intracytoplasmic vesicles, corresponding to lamellar bodies, hallmark of phospholipidosis, were detected in both hepatocyte-like and biliary-like cells after 3 days exposure to 20µM CPZ and their number increased during the following days. Co-treatment with cytokines did not seem to affect their accumulation (Fig. 4) . This observation was confirmed by measurement of transcript levels of some genes related to phospholipidosis after one and five treatments. Indeed, Adipose Differentiation-Related Protein (ADFP) and Perilipin-4 (PLIN4), two genes involved in the formation of lamellar vesicles and Acyl-CoA Desaturase (SCD1)
and Lipin-1 (LPIN1), both involved in lipid metabolism, were all up-regulated, especially after 5 daily treatments ( Effects of CPZ and cytokines on ROS generation and oxidative stress markers.
We have previously reported that oxidative stress plays a major role as both primary causal and aggravating factor in intrahepatic cholestasis induced by 50μM CPZ in HepaRG cells (Antherieu et al., 2013) . To assess whether co-treatment of CPZ with inflammatory cytokines modulated ROS generation in HepaRG cells, H 2 -DCFDA fluorescence intensity was measured after 1 and 5 additions of CPZ and/or cytokines. A 1.8-fold increase in ROS formation was observed with 20μM CPZ whereas none of the cytokines induced ROS nor altered their generation by CPZ at both time points (Fig. 5A ). Since 50μM CPZ was previously shown to cause an early oxidative stress in HepaRG cells, ROS generation was also assessed after 24-hour exposure to IL-6 or IL-1β followed by 2-or 4-hour co-treatment with 20 and 50μM CPZ. No aggravation of CPZ-induced oxidative stress was observed with cytokine pretreatment (Fig. 5B ).
Next, we measured mRNA levels of three oxidative stress-related genes, heme oxygenase 1 (HO1), manganese superoxide dismutase (MnSOD), and NF-E2-related factor (Nrf2). HO1
and MnSOD were induced by both IL-6 and IL-1β after 1 and 5 additions while CPZ caused a statistically significant increase of HO1 mRNA levels after 5 additions (2.4-fold) (Fig. 5 C, D) . When HepaRG cells were co-exposed to CPZ and either IL-6 or IL-1β, HO1 mRNA levels were statistically further augmented after 5 additions (2.7-fold with IL-6 versus 4.8-fold with IL-6 + CPZ and 1.6-fold with IL-1β versus 3.3-fold with IL-1β + CPZ) (Fig. 5C ).
MnSOD transcripts were also increased after 5 additions of cytokines and were further elevated by co-treatment with CPZ (1.7-fold with IL-6 versus 2.5-fold with IL-6 + CPZ and 2.2-fold induction with IL-1β versus 3-fold with IL-1β + CPZ) (Fig. 5D ). Expression of NF-E2-related factor (Nrf2) was not affected by any of the treatment conditions (data not shown).
Effects of CPZ and cytokines on canalicular efflux membrane transporters.
Activity of two main apical efflux transporters, BSEP and MRP2, was estimated by using their prototypical substrates TA and CDF, respectively. To determine BSEP activity, no cytokine pretreatment was performed in order to avoid any inhibitory effect on NTCP activity, the main influx transporter of TA. CPZ at 20 and 50µM induced a time-dependent This article has not been copyedited and formatted. The final version may differ from this version. 
Effects of CPZ and cytokines on F-actin distribution.
Phalloidin fluoprobe labeling was used to assess whether 20μM CPZ and/or cytokines, affected the integrity of the pericanalicular F-actin microfilament network. Whatever the treatment, F-actin distribution was not disrupted even after 5 days ( Fig.7 a, b, c).
Consequently, additional experiments were performed with 20 or 50μM CPZ treatment for 2 or 4 hours. As expected from previous studies (Antherieu et al., 2013) , at 50μM CPZ strongly altered distribution of cytoskeletal pericanalicular F-actin and bile canaliculi shape after 2 (data not shown) and 4 hours ( Fig.7 d) . These alterations were not aggravated by cytokine pre-treatment ( Fig. 7 e, f).
Effects of CPZ and cytokines on NTCP activity.
In order to investigate whether CPZ and cytokines also affected NTCP-mediated uptake activity, HepaRG cells were exposed to CPZ and/or cytokines for 1 and 5 days and then incubated with [ 3 H]-TA for 30 minutes. NTCP-dependent activity was assessed by measuring intracellular accumulation of radiolabeled TA; it was found to significantly drop by 53 or 62% and 30 or 42% in the presence of IL-6 and IL-1β after 1 or 5 days, respectively. CPZ was ineffective regardless of treatment duration. Combination of cytokines and CPZ led to a greater inhibition of NTCP activity that was statistically significant after 5 additions (83% with IL-6 + CPZ and 78% with IL-1β + CPZ) (Fig. 8 ).
Effects of CPZ and cytokines on expression of cholestasis-related genes.
To further investigate interactions between pro-inflammatory cytokines and CPZ, expression of the main genes involved in bile acids transport and synthesis was assessed by RT-qPCR (Table 2) . Several transporters were modulated by cytokines alone; the major changes were This article has not been copyedited and formatted. The final version may differ from this version. represented by down-regulation of influx transporters, especially NTCP. mRNA levels of the uptake transporter NTCP dropped by 80 and 60% in cells treated with IL-6 and IL-1β after either 1 or 5 days whereas 20µM CPZ did not cause any significant change. However, combination of CPZ with either cytokine resulted in a statistically significant additional decrease of NTCP transcripts after 5 additions (75% with IL-6 versus 91% with IL-6 + CPZ and 58% with IL-1β versus 87% with IL-1β + CPZ). In addition, IL-6 down-regulated other influx transporters, organic anion-transporting polypeptide (OATP)-B, and organic cation transporter 1 (OCT-1) mRNAs after 1 addition and OATP-C at both treatment time points. IL-1β also down-regulated OCT-1 after the first addition. Increased expression of OATP-C by CPZ was observed after only one addition and was completely antagonized by both cytokines (Table 2) .
Cytokines individually did not modulate expression of the canalicular transporter MDR3
which was down-regulated by CPZ. CPZ alone induced mRNA expression of breast cancer resistance protein (BCRP) and multidrug resistance protein (MDR1) after one addition; this increase was antagonized by both cytokines, which caused a 30-40% drop of BCRP at both time points and of MDR1 transcripts after one addition. Although neither CPZ nor IL-1β had a significant effect on BSEP transcripts, their combination caused a statistically significant decrease of BSEP mRNA expression after 5 additions. CPZ alone or with cytokines did not significantly change the relative mRNA levels of MRP2.
By contrast, CPZ associated or not with cytokines, caused increased expression of the basolateral efflux gene MRP4 at both treatment time points. Noticeably, MRP3 expression was affected neither by CPZ nor by the cytokines individually, while their combinations caused a significant decrease after both 1 and 5 additions (CPZ+IL-6) and 5 additions (CPZ+IL-1β).
Expression of cytochromes P450 genes involved in bile acid synthesis was also analyzed.
CYP8B1 mRNA levels were reduced by CPZ + IL-1β (44% drop compared to control) after 5 additions, whereas no change occurred in the presence of CPZ, IL-1β or IL-6 alone. By contrast, CYP7A1 was slightly overexpressed by co-treatment with CPZ and IL-1β after 5 additions while CYP27A1 was not affected by CPZ or cytokines, alone or in combination.
Transcripts of three major cholestasis-related nuclear receptors, the farsenoid X receptor (FXR), the pregnane X receptor (PXR) and the constitutive androstane receptor (CAR) were analyzed. Only IL-1β, alone or in combination with CPZ, slightly induced FXR expression This article has not been copyedited and formatted. The final version may differ from this version. after 5-day treatment. By contrast, PXR expression was down-regulated by both cytokines alone or in presence of CPZ after 1-day treatment and only by IL-6 and IL-6 + CPZ after 5 days. Expression of CAR was decreased by both cytokines and CPZ after 5 days.
Combination of cytokines and CPZ did not exacerbate this repression.
Discussion
Inflammation is thought to play a role in the susceptibility to iDILI. Bacterial lipopolysaccharide and pro-inflammatory cytokines are frequently used to induce an inflammatory state in animals and in vitro cell models. In the present work we used the metabolically competent HepaRG cell line to evaluate the influence of an inflammatory stress induced by the two pro-inflammatory cytokines, IL-6 and IL-1β, on the hepatotoxic and cholestatic effects of the idiosyncratic hepatotoxicant CPZ after either one or five daily treatments. Our data showed that in the presence of an inflammatory stress resulting in marked reduction of its metabolism, CPZ was more cytotoxic, amplified inhibition of NTCP activity and enhanced deregulation of expression of several other transporters. However, CPZ-induced TA efflux inhibition and bile canaliculi structures were not affected by cytokines co-treatment; most effects were amplified or observed only after 5 daily treatments.
HepaRG cells have been previously shown to exhibit an inflammatory response to the bacterial lipopolysaccharide (Aninat et al., 2008) . We showed in the current study that 1ng/ml IL-6 and 0.01ng/ml IL1-β strongly induced CRP mRNA and protein levels. IL-1β also induced mRNA and protein levels of IL-8, a pro-inflammatory CXC chemokine that plays an important role in liver inflammation, regeneration and repair (Zimmermann et al., 2011) .
These data support the conclusion that, at these selected concentrations, both cytokines induced a chronic inflammatory stress in HepaRG cells. Noticeably, while at 20µM CPZ had no effect on CRP expression after 5 days, when associated with cytokine, it enhanced CRP transcript levels as well as protein content although to a lower extent.
Pretreatment of HepaRG cells with either IL-1β or IL-6 followed by concomitant exposure to 20µM CPZ resulted in a significant although modest enhanced cytotoxic response after five repeated additions compared to treatments with the cytokines or the drug individually. These results agree with previous observations in rodents (Buchweitz et al., 2002) and primary mouse hepatocytes (Gandhi et al., 2010) . This increased cytotoxicity did not appear to be directly related to the strong inhibition of CPZ metabolism and the reduction in the formation of non-toxic metabolites in the presence of cytokines. Indeed, HepaRG cells and HepG2 cells which lack CYP3A4-and CYP1A2-mediated metabolic activity, have been reported to be nearly equally sensitive to CPZ (Aninat et al., 2006; Gerets et al., 2012) . Since expression of two oxidative stress-related genes HO1 and MnSOD were significantly induced in co-treated cells, especially after five days, increased cytotoxicity could be related to generation of an oxidative stress although an increase in ROS content could not be evidenced by the H2-DCFDA assay.
As expected, in agreement with previous reports (Abdel-Razzak et al., 1993) , the two cytokines were also found to down-regulate CYP3A4 and CYP1A2, two major CYPs together with CYP2D6 involved in CPZ oxidative metabolism (Wojcikowski et al., 2010) .
Accordingly, CPZ metabolism was highly repressed in cytokine-treated cells. Noteworthy, a strong intracellular accumulation of CPZ was observed, especially after five daily treatments.
As other cationic amphiphilic drugs, CPZ is able to induce phospholipidosis that is Noticeably, CAR was also down-regulated by CPZ after five daily treatments; this finding deserves further investigations.
An immune reaction has been evoked as an important determinant factor in CPZ-induced cholestasis but data, at least in animals, did not confirm an allergic hypersensitivity with CPZ (Mullock et al., 1983 ). An increased accumulation of neutrophils was observed in the liver of LPS+CPZ-treated rats but without evidence of cholestasis (Buchweitz et al., 2002 u  l  a  r  c  y  t  o  t  o  x  i  c  m  e  c  h  a  n  i  s  m  s  o  f  c  h  l  o  r  p  r  o  m  a  z  i  n  e  i  n  i  s  o  l  a  t  e  d  r  a  t  h  e  p  a  t  o  c  y  t  e  s  . C a n J P h y Cells were pretreated with IL-6 (1ng/ml) or IL-1β (0.01ng/ml) for 24 hours, then 20µM CPZ were added daily simultaneously with cytokines, for 1 or 5 days (1 and 5 additions respectively). Cytotoxicity was measured by the MTT colorimetric assay. Each point is the mean ± SD of three independent experiments. # p < 0.05 compared with untreated cells. Cells were exposed to IL-6 (1ng/ml) or IL-1 (0.01ng/ml) and/or CPZ (20 
